1832 Asset Management
CRL icon

1832 Asset Management’s Charles River Laboratories CRL Stock Holding History

1832 Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-160,000
Closed -$33.1M – 729
2024
Q2 		$33.1M Buy
+160,000
New +$36.3M 0.03% 231
2021
Q4 		– Sell
-105,970
Closed -$45.1M – 746
2021
Q3 		$45.1M Buy
+105,970
New +$44M 0.08% 181
2019
Q4 		– Sell
-124,600
Closed -$16.5M – 678
2019
Q3 		$16.5M Hold
124,600
– – 0.05% 195
2019
Q2 		$17.5M Buy
124,600
+41,600
+50% +$5.64M 0.06% 199
2019
Q1 		$12M Buy
+83,000
New +$10.9M 0.04% 216

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

1832 Asset Management's CRL Position: Q3 2024 in Review

1832 Asset Management sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 160,000 shares — an estimated $33.1M sold.

1832 Asset Management first reported a position in CRL in Q1 2019 and held it in 5 quarters. The position peaked at $45.1M in Q3 2021. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • 1832 Asset Management reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • 1832 Asset Management sold 160,000 Charles River Laboratories shares in Q3 2024, an estimated $33.1M.
  • 1832 Asset Management first reported a position in Charles River Laboratories in Q1 2019 and held it in 5 quarters.
  • 1832 Asset Management's Charles River Laboratories position peaked at $45.1M in Q3 2021.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on 1832 Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.